VANCOUVER, BRITISH COLUMBIA– Pyng Medical Corp. (the “Company” or “Pyng“) (TSX VENTURE:PYT) is pleased to announce that the Company has entered into a definitive agreement (the “Arrangement Agreement“) with Teleflex Incorporated... The post Teleflex to Acquire Pyng Medical appeared first on Pyng Medical.
Try Pyng Medical's FASTResponder and FASTTactical Sternal Intraosseous (IO) Infusion solutions and T-PODResponder Pelvic Stabilization Device at the International Trauma Conference taking place October 27-29, 2016 in San Antonio, Texas.
Pyng Medical will demonstrate their Sternal Intraosseous (IO) Infusion solutions at the ACEP 2016 Scientific Assembly taking place October 16-19, 2016 in Las Vegas Nevada.
Learn why the FASTResponder Sternal IO device is the best choice for EMS and Critical Care personnel
When seconds count, you need the most effective and reliable pelvic fracture treatment available. The answer is not a bedsheet. It’s a Pelvic Stabilization Device specifically designed to provide stabilizing... The post Is the T-PODResponder Pelvic Stabilization Device the Right Option for Your EMS Team? appeared first on Pyng Medical.
VANCOUVER, BRITISH COLUMBIA–Pyng Medical Corp. (TSX VENTURE:PYT) today announced financial and operating results for the fiscal year ended September 30, 2016. All amounts are in Canadian dollars unless stated otherwise.... The post Pyng Medical Corp. Reports Fiscal 2016 Financial Results appeared first on Pyng Medical.
Vancouver, B.C. Pyng Medical Corp. (PYT:TSX.V) (the “Company” or “Pyng”) announces that on October 19, 2016 it granted a total of 500,000 options to purchase common shares of the Company... The post Pyng Medical Corp. Announces Grant of Stock Options appeared first on Pyng Medical.
Vancouver, British Columbia. Pyng Medical Corp. (the “Company”) (PYT: TSX.V) is pleased to announce that it has completed amendments to the terms of certain previously issued secured convertible notes in... The post Pyng Medical Completes Convertible Note and Warrant Amendments appeared first on Pyng Medical.
It is clear that intraosseous infusion is the new treatment modality of choice in many emergency departments. In fact, it has in some areas become the first choice in vascular access, bypassing the more traditional intravenous access routes. The reasons for this involve many variables, not the least of which are the condition of the patients initial vasculature, obesity, age, or poly t...
Intraosseous (IO) Infusion has become an accepted standard of care over the last 15 years. From battlefields to ambulances and emergency rooms, the use of IO devices is rapidly increasing.